State Street SPDR S&P Pharmaceuticals ETF (XPH) Dividend Yield, History & Forecast

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.43% ($0.27 per share annually (TTM)). The most recent ex-dividend date was September 21, 2026, with payment scheduled for September 23, 2026. market capitalization is approximately $261M. Review XPH dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

XPH fund composition

XPH holds 62 positions, with 26.3% of assets in its ten largest. It charges an expense ratio of 0.35%, and manages $458.8M.

Top 10 holdings

HoldingWeight
CRNXCRINETICS PHARMACEUTICALS IN3.60%
ATAIATAIBECKLEY INC2.91%
MANEVERADERMICS INC2.86%
XERSXERIS BIOPHARMA HOLDINGS INC2.76%
PCRXPACIRA BIOSCIENCES INC2.51%
AMRXAMNEAL PHARMACEUTICALS INC2.45%
LLYELI LILLY + CO2.42%
VTRSVIATRIS INC2.31%
MAZEMAZE THERAPEUTICS INC2.29%
SEPNSEPTERNA INC2.21%

Sector allocation

Healthcare100.0%Cash & Others0.1%

Frequently Asked Questions about State Street SPDR S&P Pharmaceuticals ETF (XPH)

What is State Street SPDR S&P Pharmaceuticals ETF's dividend yield?
State Street SPDR S&P Pharmaceuticals ETF (XPH) pays a current trailing twelve-month dividend yield of 0.43%, which works out to $0.27 per share annually based on the most recent payout schedule.
When does State Street SPDR S&P Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was September 21, 2026. The next scheduled dividend payment date is September 23, 2026.
What does State Street SPDR S&P Pharmaceuticals ETF invest in?
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust...